Novartis hopes to rev up Theraflu relaunch with TV celeb Nick Cannon

Nick Cannon

Novartis ($NVS) has the face to launch a Theraflu comeback: entertainer Nick Cannon, who's advising Americans to get ready for flu season by getting vaccinated and stocking up on the over-the-counter remedy. The drug was among the consumer brands hit when a Novartis plant in Lincoln, NE, ran afoul of the FDA; the Swiss drugmaker has been working for several years to get supplies back on track. Novartis resumed shipping Theraflu from Lincoln in July, in time for the 2014-2015 flu season. Report